Bayer HealthCare appoints Pfizer’s Brandicourt as new CEO

Bayer HealthCare has appointed Olivier Brandicourt as its new Chairman of the Board of Management and member of the Bayer AG Executive Council. This role is effective as of the 1st November 2013.

Since March 2013, Professor Wolfgang Plischke has led Bayer HealthCare on an interim basis in addition to his existing duties as a Bayer AG Board Member.

"With Olivier Brandicourt we have found a strong leader with outstanding international experience and a successful track record in the healthcare industry. I am convinced that he can significantly contribute to the further growth of our healthcare business."

Bayer Group CEO, Dr. Marijn Dekkers.

Brandicourt is currently a member of Pfizer's Executive Leadership Team in New York, USA. He has 25 years of international experience in the pharmaceutical industry. Brandicourt holds a medical degree with a subspecialty in infectious diseases and tropical medicine, as well as a master's degree in biology from Paris 12 University, France.

"I am looking forward to joining the Bayer team. With a clear focus on research and development as well as a passion and dedication to improving people's lives, Bayer has an excellent track record in bringing innovation to the market."

Olivier Brandicourt.